Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10048339HBVENSG00000185803.12protein_codingSLC52A2NoNo79581Q9HAB3
TVIS30070373HIVENSG00000185803.12protein_codingSLC52A2NoNo79581Q9HAB3
TVIS30070374HIVENSG00000185803.12protein_codingSLC52A2NoNo79581Q9HAB3
TVIS44013832HTLV-1ENSG00000185803.12protein_codingSLC52A2NoNo79581Q9HAB3
TVIS44005357HTLV-1ENSG00000185803.12protein_codingSLC52A2NoNo79581Q9HAB3
TCGA Plot Options
Drug Information
GeneSLC52A2
DrugBank IDDB01440
Drug Namegamma-Hydroxybutyric acid
Target IDBE0004841
UniProt IDQ9HAB3
Regulation Typeagonist
PubMed IDs12098579; 14535954
CitationsCastelli MP, Mocci I, Pistis M, Peis M, Berta D, Gelain A, Gessa GL, Cignarella G: Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain. Eur J Pharmacol. 2002 Jun 20;446(1-3):1-5.@@Castelli MP, Ferraro L, Mocci I, Carta F, Carai MA, Antonelli T, Tanganelli S, Cignarella G, Gessa GL: Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid. J Neurochem. 2003 Nov;87(3):722-32.
GroupsApproved; Illicit; Investigational
Direct Classification
SMILESOCCCC(O)=O
Pathways
PharmGKBPA10819
ChEMBLCHEMBL1342